ArticleNature medicine2017

Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease.

Nathaniel R West et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.